Utility of CART22-65s and huCART19 in R/R ALL: Noelle V. Frey, MD, MSCE
The associate professor from Perelman School of Medicine, University of Pennsylvania, discussed co-administered CART22-65s and huCART19 in relapsed/refractory acute lymphoblastic leukemia.